Novel triple GLP-1 / GIP / glucagon receptor agonist and a pharmaceutical composition for preventing or treating obesity comprising the same

MYPI2025003834A0Undetermined Publication Date: 2024-06-23HANMI PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025003834
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-12-23
Filing Date
2023-12-22
Publication Date
2024-06-23
Patent Text Reader

Abstract

The present disclosure relates to a novel triple agonist having activities for all of GLP-1, GIP, and glucagon receptors, and use of the triple agonist for the prevention or treatment of obesity.
Need to check novelty before this filing date? Find Prior Art